Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
06/2003
06/10/2003US6576640 Rapidly penetration into central nervous system; treating noradrenaline deficiency; depression, Parkinson's disease
06/10/2003US6576634 Pharmaceutical or dietetic preparation for improvement of fertility and sperm quality
06/10/2003CA2112697C Somatotropin for increasing reproductive performance of cattle
06/06/2003CA2413479A1 Kit for reducing aching
06/05/2003WO2003045972A1 17α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATES FOR THE PRODUCTION THEREOF, AND USE OF SAID 17α-ALKYL-17β-OXY-ESTRATRIENES FOR PRODUCING MEDICAMENTS AND PHARMACEUTICAL PREPARATIONS
06/05/2003WO2003045926A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003WO2003045920A1 4-aminoquinoline compounds
06/05/2003WO2003045397A1 Dosage regimen and pharmaceutical composition for emergency contraception
06/05/2003WO2003045373A1 Use of propionyl l-carnitine or one of its pharmacologically acceptable salts for the preparation of a medicine for the treatment of la peyronie's disease
06/05/2003WO2003045369A2 Use of l isomers of amino acid derivatives of hydroxyguanidine for producing no, pharmaceutical compositions containing same and pharmaceutical uses
06/05/2003WO2003045361A1 Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds
06/05/2003WO2003045338A1 Compositions comprising phenyl-glycine derivatives
06/05/2003WO2003045333A2 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003WO2003045318A2 Manipulation of cytokine levels using cd83 gene products
06/05/2003WO2003045315A2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/05/2003WO2003045313A2 2-aminoquinoline compounds
06/05/2003WO2003045229A2 Methods and compositions for treating cancer
06/05/2003WO2002081665A3 Implantation serine proteinases
06/05/2003WO2002068548A3 Use of erss-selective ligands for regulating fertility and compounds useful therefore
06/05/2003WO2002048124A3 Piperazine derivatives
06/05/2003US20030106082 Transgenic stem cells, formed by dissociating blastomeres, are cultured, impregnated within surrogate; animals models; gene therapy
06/05/2003US20030105318 G-protein transmembrane domain; protein synthesis inhibitor; neurotransmitter
06/05/2003US20030105285 Odorant receptors
06/05/2003US20030105148 Selective estrogen receptor modulators
06/05/2003US20030105135 Adrenergic receptors; gastrointestinal disorders, dietetics, urogenital disorders, antidiabetic agents
06/05/2003US20030105123 For therapy of respiratory system disorders
06/05/2003US20030105114 Methods of treatment and kits comprising a growth hormone secretagogue
06/05/2003US20030105107 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines
06/05/2003US20030105106 5-HT receptor ligands and uses thereof
06/05/2003US20030105090 For therapy of cancer, diabetes
06/05/2003US20030105087 New polycyclic azaindole compounds
06/05/2003US20030105074 Phthalazine compounds and therapeutic agents for erectile dysfunction
06/05/2003US20030104980 Treating sexual desire disorders with flibanserin
06/05/2003US20030104975 Useful for identification of compounds that induce or inhibit the recruitment of the p160 family cofactors, especially TIF-2 and/ or SRCs cofactors (Translation initiation factor-2 and steroid receptor cofactors)
06/05/2003US20030104570 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
06/05/2003US20030104553 Isolation of human chorionic gonadotropin protein through ion exchange and size exclusion chromatography
06/05/2003US20030104478 Screening modulators of g-protein activity: for use in treatment of nervous system disorders
06/05/2003US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003CA2468256A1 Compositions comprising phenyl-glycine derivatives
06/05/2003CA2468184A1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use as medicine
06/05/2003CA2468159A1 4-aminoquinoline compounds
06/05/2003CA2468015A1 2-aminoquinoline compounds
06/05/2003CA2466867A1 Treatment of hyperproliferative diseases using active vitamin d analogues
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2463592A1 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
06/04/2003EP1316547A1 Novel crystals of n-hydroxy-2(s)-methyl-5-ethoxymethoxy -4(s)- n-(4-phenoxyphenylcarbonyl)amino]pentanamide, process for their production and medicines containing the crystals as the active ingredient
06/04/2003EP1316316A1 Preparations for oral administration
06/04/2003EP1315800A2 Human proteases
06/04/2003EP1315758A2 Methods and reagents for protease inhibition
06/04/2003EP1315751A2 Two receptors of meiosis activating sterols designated sam1a and sam1b
06/04/2003EP1315729A1 Compounds in the form of homodimeric, heterodimeric and/or homo and heteromultimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterasis-mediated diseases or dysfunction
06/04/2003EP1315727A2 7-oxo pyridopyrimidines
06/04/2003EP1315714A2 Quinazoline derivatives as alpha-1 adrenergic antagonists
06/04/2003EP1315700A2 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine
06/04/2003EP1315521A2 Method for improving the efficacy of artificial insemination of non-human animals
06/04/2003EP1315507A2 Hpv-specific short-mers
06/04/2003EP1315502A1 Method for treating erectile dysfunction and increasing libido in men
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315476A2 Nitric oxide-producing hydrogel materials
06/04/2003EP1252150B1 Heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
06/04/2003EP1155014B1 New benzimidazole compounds for use as active therapeutic substances, process for the preparation of these compoudns and pharmaceutical compositions comprising them
06/04/2003EP1143997B1 Tumor necrosis factor antagonists and their use in endometriosis treatment
06/04/2003EP1140945B1 Fused 1,2,4-thiadiazine derivatives, their preparation and use
06/04/2003EP1075476B1 Novel benzimidazoles and benzoxazoles
06/04/2003EP1038863B1 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
06/04/2003EP0938496B1 Heptapeptide oxytocin analogues
06/04/2003EP0863875B1 New 4-(oxyalkoxyphenyl)-3-oxy-piperidines for treating heart and kidney insufficiency
06/04/2003EP0775118B1 Benzimidazole derivatives having dopaminergic activity
06/04/2003CN1422271A Pyrrolopyrimidinone derivatives, process of preparation and use
06/04/2003CN1422263A Estrogen agonist/antagonist metabolites
06/04/2003CN1422262A 2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
06/04/2003CN1422157A Divided dose therapies with vascular damaging activity
06/04/2003CN1421225A Recipe and prepn process of Chinese medicine for treating sterility
06/04/2003CN1421219A Chinese medicine for treating women's ovary cancer and uterine myoma
06/04/2003CN1110558C Novel growth/differentiation factor of the TGF-ÔÇÿbetaÔÇÖfamily
06/04/2003CN1110493C Aminothiophene carboxylic acid amides and the use thereof as phosphodiesterase inhibitors
06/04/2003CN1110485C 1-arylsulphonyl, aryl (thio) Carbonyl pyridazino derivatives and producing process thereof
06/04/2003CN1110484C 2-(cary lphenyl) amino-imidazoline derivatives
06/04/2003CN1110327C Novel device for transdermal administration of trimegestone
06/03/2003US6573390 Muscle relaxant, hypotensive agent, respiratory system disorders, gastrointestinal disorders, fertility, incontinence, shock, antiinflammatory agents, immunology, bone disorders, antiproliferative agents
06/03/2003US6573287 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase IV and method
06/03/2003US6573283 Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
06/03/2003US6573270 Endothelin receptor antagonists
06/03/2003US6573066 FtsH from Staphylococcus aureus
06/03/2003CA2275554C Intranasal formulations for treating sexual disorders
06/03/2003CA2047858C (quinolin-2-ylmethoxy)tetrahydrocarbazoles as inhibitors of the biosynthesis of leukotrienes
05/2003
05/30/2003WO2003044058A2 Medical use of antibodies directed against human matrix metalloproteinases or related tissue proteinases for the treatment of abnormal uterine bleeding and endometriosis
05/30/2003WO2003044056A2 Chemically-modified human growth hormone conjugates
05/30/2003WO2003044006A1 Substituted benzopyrans as selective estrogen receptor-beta agonists
05/30/2003WO2003043982A1 Derivatives of andrimide and moiramide b having antibacterial properties
05/30/2003WO2003043652A2 The use of leptin in fertility
05/30/2003WO2003043628A1 Medicament for the treatment of viral skin and tumour diseases
05/30/2003WO2003043612A1 Micronized film-forming powder comprising an active substance
05/30/2003WO2003008448A3 Novel human proton-gated channels
05/30/2003WO2002096363A3 Method for treating fibrotic diseases or other indications
05/30/2003WO2002066040A3 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
05/30/2003WO2002016313A3 Integrin receptor inhibitors
05/30/2003CA2468018A1 Micronized film-forming powder comprising an active substance
05/30/2003CA2467731A1 Chemically-modified human growth hormone conjugates
1 ... 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 ... 557